Last reviewed · How we verify

NCT05272345

Fibromyalgia and Sexual Functıonal Dısorder and Sexual Therapy

Active, enrolled NA Last updated 18 July 2024
What this trial tests

NA trial testing sexual therapy in Fibromyalgia in 30 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
14 February 2022
Primary endpoint
14 May 2024
14 December 2025

Quick facts

Lead sponsorKanuni Sultan Suleyman Training and Research Hospital
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment30
Start date14 February 2022
Primary completion14 May 2024
Estimated completion14 December 2025
Sites2 locations across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Kanuni Sultan Suleyman Training and Research Hospital

Who can join

Adults 15 to 49, female only, with Fibromyalgia or Sexual Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

investigators aim to re-evaluate the findings of Fibromyalgia in patients whose FSFI scores return to normal levels after sexual therapy, by identifying patients with sexual dysfunction according to the FSFI scale applied in patients investigators followed up with a diagnosis of fibromyalgia, and when investigators consulted with obstetricians.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of sexual therapy

Trials testing the same drug.

Other recruiting trials for Fibromyalgia

Currently open trials in the same condition.

Other Kanuni Sultan Suleyman Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05272345.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing